Showing 1 - 8 results of 8 for search 'A. Yu. Savchenko', query time: 0.02s Refine Results
  1. 1
    Simvastatin in primary and secondary prevention of cerebrovascular insufficiency

    Simvastatin in primary and secondary prevention of cerebrovascular insufficiency by E. A. Melnik, G. A. Vlasova, A. Yu. Savchenko

    Published 2007-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Therapeutic and biopharmaceutical assessment of indapamide medications

    Therapeutic and biopharmaceutical assessment of indapamide medications by G. V. Ramenskaya, S. V. Nedogoda, I. E. Shokhin, A. Yu. Savchenko, V. S. Shlykov

    Published 1970-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study

    Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study by N. S. Dubovik, D. F. Guranda, G. V. Ramenskaya, D. G. Tovbin, D. N. Tarasov, A. Yu. Savchenko, V. S. Arnautov

    Published 2022-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method

    Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method by A. V. Aleshina, T. N. Komarov, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, V. V. Davydanova, A. Yu. Savchenko, I. E. Shohin

    Published 2021-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Hygienic Monitoring of Working Area Air Pollution by Particulate Matter of ticagrelator in the Pharmaceutical Factory

    Hygienic Monitoring of Working Area Air Pollution by Particulate Matter of ticagrelator in the Pharmaceutical Factory by I. A. Pozharnov, A. S. Simakov, N. A. Shulga, A. Yu. Savchenko, O. I. Perederyaev, L. S. Synkova, Yu. V. Medvedev, E. N. Fisher

    Published 2022-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Application of <i>in vitro</i> studies to predict the pharmacokinetics of rivaroxaban tablets

    Application of <i>in vitro</i> studies to predict the pharmacokinetics of rivaroxaban tablets by A. V. Suvorova, P. A. Losenkova, Yu. V. Medvedev, E. A. Malashenko, K. K. Karnakova, N. S. Bagaeva, A. Yu. Savchenko, A. M. Poluyanov, I. E. Shohin

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum

    Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum by O. A. Eliseeva, M. A. Kolganova, I. E. Shokhin, S. P. Dementyev, A. M. Vlasov, A. A. Zamyatnin, N. S. Dubovik, A. Yu. Savchenko, N. V. Dozmorova, V. G. Luzhanin

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Russia) and Avastin® (Manufactured by F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Male Volunteers

    A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Ru... by M. A. Kolganova, N. S. Bagaeva, Yu. V. Medvedev, I. E. Shohin, A. V. Demchinskaya, T. N. Palkina, D. A. Salazanov, G. E. Konopleva, M. S. Sheremeteva, Sh. Z. Archuadze, Ya. V. Lavrovsky, A. Yu. Savchenko, M. Yu. Samsonov

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: